NSECapacity additionExpansion3d ago
Rainbow Childrens Medicare Limited
Capacity addition
Rainbow Childrens Medicare Limited has informed the Exchange about the proposed acquisition of 64% partnership interest and corresponding capital contribution in Super Prime Medical Care LLP for ₹19.84 Cr. The acquisition is intended to acquire a running children's hospital at Nellore, Andhra Pradesh, and augment the hospital's capacity by approximately 30 beds.
BSECompany Update▲ PositiveM&A3d ago
Rainbow Children's Medicare Ltd
Intimation for acquisition
Rainbow Children's Medicare Ltd has announced the acquisition of 64% partnership interest and corresponding capital contribution in Super Prime Medical Care LLP for ₹19.84 Cr. The acquisition is intended to expand the company's healthcare services and strengthen its business operations in Andhra Pradesh.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates3d ago
Ivalue Infosolutions Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Ivalue Infosolutions Limited has informed the Exchange about a scheduled in-person meeting with analysts and investors on August 03, 2026, in Mumbai, to discuss industry and company-specific developments.
BSECorp. ActionDividend3d ago
Steelcast Ltd
The Board has fixed the Record Date for the First Interim Dividend 2026-27
Steelcast Ltd has fixed the record date for the first interim dividend of FY 2026-27 as August 7, 2026.
BSEOthersESG3d ago
LG Electronics India Ltd
Business Responsibility and Sustainability Report FY 2026-27
LG Electronics India Ltd has released its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26, which includes details of its business activities, products, and operations.
NSEAcquisition▲ Positiveacquisition3d ago
Rainbow Childrens Medicare Limited
Acquisition
Rainbow Children's Medicare Limited has informed the Exchange about Acquisition of 64% partnership interest and corresponding capital contribution in Super Prime Medical Care LLP for an aggregate consideration of ₹19.84 Cr.
BSECorp. ActionDividend3d ago
Steelcast Ltd
The Board has approved the First Interim Dividend for the Financial Year 2026-27.
Steelcast Ltd has approved a first interim dividend for FY 2026-27 at Rs. 0.45 per equity share, payable within 30 days. The company also approved setting up of a greenfield foundry with a capacity of 8500 Tons, to be added within 2 years, at an investment of Rs. 120 Crores.
BSECorp. ActionDividend3d ago
Tasty Bite Eatables Ltd
Intimation to fixed the record date 6th August, 2026 for the Dividend in the 42 annual general meeting to be held on 13th august, 2026
Tasty Bite Eatables Ltd has fixed the record date for the payment of dividend for the financial year 2025-26 as August 6, 2026, and the annual general meeting will be held on August 13, 2026.
NSERecord DateDividend3d ago
Tasty Bite Eatables Limited
Record Date
Tasty Bite Eatables Limited has announced the record date for the payment of dividend and annual general meeting for the financial year 2025-26.
NSEShareholders meeting3d ago
Mangalam Cement Limited
Shareholders meeting
Mangalam Cement Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 21, 2026.
NSEAnalysts/Institutional Investor Meet/Con. Call Updatesanalysts_meet3d ago
Britannia Industries Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Britannia Industries Limited will host an Investors/Analysts Conference Call (Group Meet) on Friday, 7th August, 2026 to discuss the financial results and operations for the quarter ended 30th June, 2026.
BSECompany Update3d ago
Quantum Digital Vision India Ltd
NEWSPAPER PUBLICATIONS
Quantum Digital Vision India Ltd has made an announcement under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the publication of a newspaper advertisement.
NSEInvestor PresentationResults3d ago
MAS Financial Services Limited
Investor Presentation
MAS Financial Services Limited has informed the Exchange about Investor Presentation for the quarter ended on June 30, 2026.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults3d ago
PTC India Financial Services Limited
Analysts/Institutional Investor Meet/Con. Call Updates
PTC India Financial Services Limited has informed the Exchange about the link of recording of the conference call held on July 29, 2026, regarding the financial results for the quarter ended June 30, 2026.
BSECompany UpdateResults3d ago
Britannia Industries Ltd
Pursuant to Regulation 30 read with Clause 15 of Para A of Part A of Schedule III of the SEBI Listing Regulations, 2015, this is to inform you that the Company will host an Investors/Analysts ....
Britannia Industries Ltd will host an Investors/Analysts Conference Call on August 7, 2026, to discuss financial results and operations for the quarter ended June 30, 2026.
BSEBoard MeetingResults3d ago
Modison Ltd-$
Modison Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve approving unaudited Financial Results ....
Modison Ltd has scheduled a Board meeting on August 13, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026.
NSEPress Release▲ PositiveResults3d ago
OnEMI Technology Solutions Limited
Press Release
OnEMI Technology Solutions Limited, also known as Kissht, has announced its unaudited financial results for the quarter ended June 30, 2026, reporting a 61% YoY growth in AUM to ₹8,001 Cr and a 59% YoY increase in PAT to ₹95 Cr.
BSEAGM/EGMResults3d ago
Mangalam Cement Ltd
Annual General Meeting (AGM) scheduled to be held on 21 August 2026
Mangalam Cement Ltd's 50th Annual General Meeting (AGM) scheduled for August 21, 2026, to consider financials, dividend, and director appointments.
BSECompany Update▲ PositiveOrder Win3d ago
Sun Pharmaceutical Industries Ltd
Sun Pharma receives approval to manufacture and market semaglutide in Brazil
Sun Pharmaceutical Industries Ltd has received approval from the Brazilian Health Regulatory Agency, ANVISA, to manufacture and market semaglutide injection in Brazil for the treatment of inadequately controlled type 2 diabetes mellitus.
NSEPress Release▲ PositiveOrder Win3d ago
Sun Pharmaceutical Industries Limited
Press Release
Sun Pharmaceutical Industries Limited has received approval from the Brazilian Health Regulatory Agency, ANVISA, to manufacture and market semaglutide in Brazil for the treatment of inadequately controlled type 2 diabetes mellitus.